Tributyrin-Max

Postbiotic Colon and Microbiome Support*

60, 750 mg tributyrin capsules

Free shipping for 1-3 bottles.

SLOWS INTESTINAL MOTILITY - If food passes through your digestive system too quickly, leading to loose stool, tributyrin is an ideal choice to firm up bowel movements and decrease bloating.* Tributyrin is the superior, slow-release form of butyrate, a short chain fatty acid (also known as a postbiotic) produced when a healthy gut microbiome  ferments fiber. It is an ideal supplement to take while on antibiotics, which decrease the natural ability of the gut microbiome to produce butyrate.*

SUPPORTS A HEALTHY GUT MICROBIOME AND SEALS UP A LEAKY GUT – By feeding the cells lining the colon, Tributyrin-Max helps restore and seal up the lining of the colon, encouraging the growth of butyrate-producing anaerobic bacteria.* This in turn may decrease food sensitivities and histamine reactions.*

MODERATES VISCERAL SENSITIVITY AND DECREASES INFLAMMATION – Decreases sensitivity to digestive pain and discomfort.* Supports the formation of regulatory T-cells, which reduce inflammation and suppress autoimmune responses.*

HIGHEST DOSE CAPSULE – At 60 capsules of 750 mg, Tributyrin-Max is the highest-dose tributyrin capsule currently available, requiring fewer pills to achieve an effective dose.

ENTERIC CAPSULE –  Tributyrin-Max contains 750 mg of tributyrin powder in a plant-based, enteric capsule for delivery through the stomach acid to your intestines. Non-GMO, third-party tested gluten-free and dairy-free and brought to you by the host of The Perfect Stool podcast.  

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

________________________________________________________________________________________________

Butyrate (of which tributyrin is the superior form) is a well-studied but relatively new and not well-known supplement.

Some of the impacts of butyrate in the gastrointestinal tract, established by peer-reviewed research, which can be of help to sufferers of IBS-D or irritable bowel syndrome with diarrhea (or loose stool) include:

• Slowing intestinal motility¹ meaning more water absorbed, so harder stools with a clean wipe
• Decreasing inflammation²
• Moderating visceral sensitivity meaning decreased sensitivity to pain in the internal organs
• Increasing gut hypoxia and sealing up leaky gut (by removing oxygen that favors inflammatory bacteria)³ which may in turn decrease food sensitivities and histamine reactions
• inhibition and prevention of colorectal cancer^7,8

Research has also confirmed its impacts beyond the gut:

• Autoimmune Disease: Supporting the formation of regulatory T-cells, which reduces inflammation and suppresses autoimmune responses⁴
• Type 2 Diabetes: Lowering hemoglobin A1C and reducing blood-glucose spikes in people with Type 2 diabetes, reducing insulin resistance, reducing obesity-associated inflammation⁵
• Obesity: Prevention of high-fat diet (HFD)-induced obesity and obesity-associated disorders in animal models⁶

Why is Tributyrin better than other forms of butyrate?

The Tributyrin form of butyrate (as opposed to sodium butyrate, potassium butyrate, magnesium butyrate or calcium butyrate forms) is superior because of low odor, chemical stability, rapid absorption in plasma, and ability to diffuse through biological membranes, releasing butyrate over time directly into cells as opposed to butyrate, which is metabolized rapidly as soon as it enters the cells lining the colon.⁷

What is butyrate?

Butyrate is a form of butyric acid, which is a short chain fatty acid (SCFA) that is created through the fermentation of fiber in our colon by beneficial bacteria. It feeds the colonocytes, or cells lining the colon. Metabolism of butyrate by the colonocytes is responsible for more than 70% of oxygen consumption⁹, which means its presence helps maintain an anaerobic environment in the gut, favorable to anaerobic bacteria that promote a healthy gut barrier and continued production of butyrate¹⁰. In animal models, use of 3 days of oral antibiotics decimated the gut’s ability to produce butyrate from fiber and increased oxygen levels in the gut. This promotes the growth of facultative anaerobic bacteria (or bacteria that can live with or without the presence of oxygen), typically proteobacteria, leading to loose stool and an influx of oxygen, which further increases the presence of proteobacteria. This leads to an inflamed and leaky colon. Supplemental butyrate can help reverse this cycle and restore the colon to a healthy balance of anaerobic and facultative anaerobic bacteria.

________________________________________________________________________________________________

1. Canani, RB et al.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011 Mar 28; 17(12): 1519–1528. doi:10.3748/wjg.v17.i12.1519

2. Siddiqui MT, Cresci GAM. The Immunomodulatory Functions of Butyrate. J Inflamm Res. 2021;14: 6025–6041. doi:10.2147/JIR.S300989

3. Kelly CJ et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015;17: 662–671. doi: 10.1016/j.chom.2015.03.005

4. Takahashi, D et al. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells. EBioMedicine. 2020; 58: 102913. doi:10.1016/j.ebiom.2020.102913

5. Arora T & Tremaroli V. Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes. Front Endocrinol. 2021;12: 761834. doi: 10.3389/fendo.2021.761834

6. Coppola S, Avagliano C, Calignano A, Berni Canani R. The Protective Role of Butyrate against Obesity and Obesity-Related Diseases. Molecules. 2021;26. doi: 10.3390/molecules26030682

7. Gaschott, T et al. Tributyrin, a Stable and Rapidly Absorbed Prodrug of Butyric Acid, Enhances Antiproliferative Effects of Dihydroxycholecalciferol in Human Colon Cancer Cells. The Journal of Nutrition.  2001 June;131(6): 1839–1843, https://doi.org/10.1093/jn/131.6.1839

8. McNabney, S M & Henagan, T M,  Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance. Nutrients. 2017 Dec 12;9(12):1348. doi: 10.3390/nu9121348

9. Zeng, H., Lazarova, D. L., & Bordonaro, M. (2014). Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World journal of gastrointestinal oncology, 6(2), 41. doi: 10.4251/wjgo.v6.i2.41

10. Mailing, L. (2019). The Oxygen Gut Dysbiosis Connection. https://www.lucymailing.com/the-oxygen-gut-dysbiosis-connection/